Bruker | BRKR - Cash And Equivalent


Bruker reported $133.4M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
ABB USD 3.87B 542M Jun/2026
Agilent USD 1.81B 49M Mar/2026
Ametek USD 481.25M 23.3M Mar/2026
Bio Techne USD 209.82M 36.94M Mar/2026
Bio-Rad Laboratories USD 507.2M 22.6M Mar/2026
Bruker USD 133.4M 165.4M Mar/2026
Charles River Laboratories USD 191.83M 21.94M Mar/2026
Danaher USD 5.7B 1.09B Mar/2026
Fujikura JPY 153.99B 12.32B Sep/2025
Furukawa JPY 15.46B 409M Sep/2025
General Electric Aerospace USD 9.35B 1.64B Jun/2026
Hitachi JPY 1.28T 412.69B Sep/2025
Illumina USD 1.42B 368M Dec/2025
IQVIA Holdings USD 1.95B 33M Mar/2026
Mettler Toledo International USD 66.89M 2.18M Dec/2025
Mitsubishi Electric JPY 862.84B 105.51B Sep/2025
Mitsubishi Heavy Industries JPY 716.1B 44.22B Sep/2025
Myriad Genetics USD 124.4M 25.2M Mar/2026
Nikon Corporation JPY 164.74B 1.15B Jun/2025
Olympus JPY 147.24B 93.98B Sep/2025
Repligen USD 582.65M 16.63M Mar/2026
Revvity USD 860.32M 59.54M Mar/2026
Smiths GBP 345M 47M Dec/2025
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Waters USD 462M 125.83M Mar/2026